Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Total Liabilities (2022 - 2025)

Historic Total Liabilities for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $23.1 million.

  • InflaRx's Total Liabilities rose 4624.24% to $23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 4624.24%. This contributed to the annual value of $15.8 million for FY2024, which is 1666.53% down from last year.
  • Latest data reveals that InflaRx reported Total Liabilities of $23.1 million as of Q3 2025, which was up 4624.24% from $18.6 million recorded in Q2 2025.
  • In the past 5 years, InflaRx's Total Liabilities registered a high of $23.1 million during Q3 2025, and its lowest value of $8.3 million during Q1 2023.
  • Its 4-year average for Total Liabilities is $15.1 million, with a median of $14.3 million in 2022.
  • Per our database at Business Quant, InflaRx's Total Liabilities crashed by 6295.29% in 2023 and then surged by 6148.77% in 2024.
  • InflaRx's Total Liabilities (Quarter) stood at $14.3 million in 2022, then surged by 32.3% to $19.0 million in 2023, then dropped by 17.72% to $15.6 million in 2024, then surged by 48.27% to $23.1 million in 2025.
  • Its Total Liabilities was $23.1 million in Q3 2025, compared to $18.6 million in Q2 2025 and $17.4 million in Q1 2025.